Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sang, Wei
NCT05755828: Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma	Recruiting	2	30	RoW	ASCT+CAR-T Cell Infusion	The Affiliated Hospital of Xuzhou Medical University	B-cell Lymphoma	12/24	12/24
NCT05744037: Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells	Recruiting	2	30	RoW	regimen with BTK inhibitor +Anti-CD19 CAR T cells	The Affiliated Hospital of Xuzhou Medical University	B-cell Non Hodgkin Lymphoma	01/25	01/25
NCT05745181: Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma	Recruiting	2	20	RoW	CAR-T Cell Infusion	The Affiliated Hospital of Xuzhou Medical University	Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma	01/26	01/26
XYFY2023-KL123-01, NCT05941156: Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia	Recruiting	2	20	RoW	Anti-CD56 CAR T	The Affiliated Hospital of Xuzhou Medical University	Extranodal NK T Cell Lymphoma, NK-Cell Leukemia	05/26	05/26
NCT06614998: Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study	Recruiting	N/A	80	RoW	Patients diagnosed with HLH-94 should be treated as soon as possible	The Affiliated Hospital of Xuzhou Medical University	Hemophagocytic Syndrome	05/26	05/26